The attitudes of women patients with cancer were explored when they were invited to participate in one of three randomised trials that included chemotherapy at two university centres and a satellite centre. Fourteen patients participating in and 15 patients declining trials were interviewed. Analysis was based on the constant comparative method. Most patients voiced positive attitudes towards clinical research, believing that trials are necessary for further medical development, and most spontaneously argued that participation is a moral obligation. Most trial decliners, however, described a radical change in focus as they faced the actual personal choice. Almost no one got an impression of clinical equipoise between treatments in the trial...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
Background. Accurate measurement of attitudes toward participation in cancer treatment trials (CTs) ...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background:Patient accrual into cancer clinical trials remains at low levels. This survey elicited a...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background:Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligi...
This paper reports on the reasons why patients agreed to or declined entry into randomized trials of...
BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eli...
BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eli...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
Background. Accurate measurement of attitudes toward participation in cancer treatment trials (CTs) ...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
The attitudes of women patients with cancer were explored when they were invited to participate in o...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background:Patient accrual into cancer clinical trials remains at low levels. This survey elicited a...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background: Patient accrual into cancer clinical trials remains at low levels. This survey elicited...
Background:Barriers to randomised clinical trial (RCT) recruitment include failure to identify eligi...
This paper reports on the reasons why patients agreed to or declined entry into randomized trials of...
BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eli...
BACKGROUND: Barriers to randomised clinical trial (RCT) recruitment include failure to identify eli...
BACKGROUND: barriers to randomised clinical trial (RCT) recruitment include failure to identify elig...
Background: Patients invited to take part in a clinical trial may evoke an archetype on which they m...
Background. Accurate measurement of attitudes toward participation in cancer treatment trials (CTs) ...